Summary
The mode of action of interferon in JLSV 5-cells, chronically infected with Rauscher murine leukemia virus (MLV), was studied by examining the fate of preexisting labelled viral RNA in interferon-treated cells and by determining the infectivity/physical particle ratio of cell-associated and extracellular virus.
Interferon added together with3H-uridine inhibited the production of labelled virus particles even when it was only allowed to act after all viral RNA synthesis had been stopped by actinomycin D. This indicated that the interferon-induced antiviral state primarily functions at a posttranscriptional step. When interferon was given after a3H-uridine pulse label and arrest of label incorporation by glucosamine and unlabelled uridine, it prevented a portion of the preexisting radioactive RNA from occurring in extracellular particles. However, part of the labelled viral RNA had reached a stage beyond which interferon could not prevent it from occurring in extracellular virus particles.
The notion that interferon primarily affects release of fully assembled and enveloped MLV particles may be eliminated: interferon-treatment did not affect the release of particle-bound reverse transcriptase in cells treated with cycloheximide after the antiviral state had been established.
It was confirmed that interferon-treated JLSV 5-cells contained an increased number of virus particles associated with the cell membrane. However, these particles were found to have a reduced infectivity compared to those associated with control cells, thus confirming the view that virions produced by interferon-treated cells are defective; perhaps lacking in certain components.
Similar content being viewed by others
References
Allen, P. T., Schellekens, H., van Griensven, L. J. L. D., Billiau, A.: Differential sensitivity of Rauscher murine leukaemia virus (MuLV-R) to interferons in two interferon-responsive cell lines. J. gen. Virol.31, 429–435 (1976).
Baron, S., Buckler, C. E., Dianzani, F.: Some determinants of the interferon-induced antiviral state. In:Wolstenholme, G. E. W., O'Conner, M. (eds.), Ciba Foundation Symposium on Interferon, 186–200. London: J. & A. Churchill Ltd. 1967.
Bassin, R. H., Tuttle, N., Fischinger, P. J.: Rapid culture assay technique for murine leukemia viruses. Nature229, 564–566 (1971).
Billiau, A., Sobis, H., de Somer, P.: Influence of interferon on virus particle formation in different oncornavirus carrier cell lines. Int. J. Cancer12, 646–653 (1973).
Billiau, A., Edy, V. G., Sobis, H., de Somer, P.: Influence of interferon on virusparticle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release. Int. J. Cancer14, 335–340 (1974).
Billiau, A., Edy, V. G., de Clercq, E., Heremans, H., de Somer, P.: Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. III. Survey of effects on A-, B- and C-type oncornaviruses. Int. J. Cancer15, 947–953 (1975).
Billiau, A., Heremans, H., Allen, P. T., de Somer, P.: Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. IV. Relevance to the potential application of interferon in natural infectious diseases. J. inf. Dis.133 (suppl.), A 51-A 55 (1976).
Billiau, A., Heremans, H., Allen, P. T., de Maeyer-Guignard, J., de Somer, P.: Trapping of oncornavirus particles at the surface of interferon-treated cells. Virology73, 537–542 (1976).
Chang, E. H., Friedman, R. M.: A large glycoprotein of Moloney leukemia virus derived from interferon-treated cells. Biochem. biophys. Res. Commun.77, 392–398 (1977).
Chang, E. H., Myers, M. W., Wong, P. K. Y., Friedman, R. M.: The inhibitory effect of interferon on a temperature-sensitive mutant of Moloney murine leukemia virus. Virology77, 625–636 (1977).
Chang, E. H., Mims, S. J., Triche, T. J., Friedman, R. M.: Interferon inhibits mouse leukemia virus release: an electron microscope study. J. gen. Virol.34, 363–368 (1977).
Dianzani, F., Baron, S., Buckler, C. E.: Effect of metabolic inhibitors on the antiviral action of the interferon system. In:Rita, G. (ed.), The Interferons, 147–159. New York: Academic Press 1968.
Friedman, R. M.: Inhibition of arbovirus protein synthesis by interferon. J. Virol.2, 1081–1085 (1968).
Friedman, R. M., Ramseur, J. M.: Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon. Proc. Nat. Acad. Sci. U.S.A.71, 3542–3544 (1974).
Friedman, R. M., Chang, E. H., Ramseur, J. M., Myers, M. W.: Interferondirected inhibition of chronic murine leukemia virus production in cell cultures: lack of effect on intracellular viral markers. J. Virol.16, 569–574 (1975).
Friedman, R. M., Costa, J. C., Ramseur, J. M., Myers, M. W., Jay, F. T., Chang, E. H.: Persistence of the viral genome in interferon-treated cells infected with oncogenic or nononcogenic viruses. J. inf. Dis.133 (suppl.), A 43-A 50 (1976).
Miller, M. F., Allen, P. T., Dmochowski, L.: Quantitative studies of oncornaviruses in thin sections. J. gen. Virol.21, 57–68 (1973).
Pitha, P. M., Rowe, W. P., Oxman, M. N.: Effect of interferon on exogenous, endogenous, and chronic murine leukemia virus infection. Virology70, 324–338 (1976).
Pitha, P. M., Staal, S. P., Bolognesi, D. P., Denny, T. P., Rowe, W. P.: Effect of interferon on murine leukemia virus infection. II. Synthesis of viral components in exogenous infection. Virology79, 1–13 (1977).
Russell, W. C., Newman, C., Williamson, D. H.: A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature253, 461–462 (1975).
Samuel, C. E., Joklik, W. K.: A protein synthesizing system from interferontreated cells that discriminates between cellular and viral messenger RNAs. Virology58, 476–491 (1974).
Scholtissek, C.: Detection of an unstable RNA in chick fibroblasts after reduction of the UTP pool by glucosamine. Europ. J. Biochem.24, 358–365 (1971).
Shapiro, S. Z., Strand, M., Billiau, A.: Synthesis and cleavage processing of oncornavirus proteins during interferon inhibition of virus particle release. Infect. Immun.16, 742–747 (1977).
van Griensven, L. J. L. D., Baudelaire, M. F., Peries, J., Emanoil-Ravicovitch, R., Boiron, M.: Studies on the biosynthesis of murine leukemia virus RNA. I. Some properties of Rauscher leukemia virus isolated from interferon treated JLSV 5 cells (Proc. of the second Lepetit Colloquium), 145–153. Amsterdam: North Holland Publishing Company 1970.
Williams Wertz, G.: Method of examining viral RNA metabolism in cells in culture: metabolism of vesicular stomatitis RNA. J. Virol.16, 1340–1344 (1975).
Wright, B. S., Lasfargues, J. C.: Long-term propagation of the Rauscher murine leukemia virus in tissue culture. J. Nat. Cancer Inst.35, 319–327 (1965).
Wong, P. K. Y., Yuen, P. H., Mac Leod, R., Chang, E. H., Myers, M. W., Friedman, R. M.: The effect of interferon onde novo infection of Moloney murine leukemia virus. Cell10, 245–252 (1977).
Wu, A. M., Reitz, M. S., Paran, M., Gallo, R. C.: Mechanism of stimulation of murine type-C RNA tumor virus production by gluco-corticoids: post-transcriptional effects. J. Virol.14, 802–812 (1974).
Wu, A. M., Schultz, A., Gallo, R. C.: Synthesis of type C virus particles from murine cultured cells induced by iododeoxyuridine. V. Effect of interferon and its interaction with dexamethasone. J. Virol.19, 108–117 (1976).
Author information
Authors and Affiliations
Additional information
With 4 Figures
Rights and permissions
About this article
Cite this article
Billiau, A., Heremans, H., Allen, P.T. et al. Interferon inhibits C-type virus at a posttranscriptional, prerelease step. Archives of Virology 57, 205–220 (1978). https://doi.org/10.1007/BF01315085
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01315085